Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
ACADIA Pharmaceuticals Inc. (ACAD)
USD25.99
+0.50 (+1.96%)
US NASDAQ Healthcare Biotechnology
Address
12830 El Camino Real 92130
San Diego, CA, US
San Diego, CA, US
CEO
Catherine E. Owen Adams
Website
acadia-pharm.com
IPO
2004-05-27
CIK 1070494 ISIN US0042251084
Description
ACADIA Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics. Their core focus lies in addressing critical unmet medical needs within the realm of central nervous system (CNS) disorders. The company's marketed product, NUPLAZID (pimavanserin), is prescribed for the management of hallucinations and delusions associated with Parkinson's disease psychosis. Beyond its commercialized offering, ACADIA maintains a robust development pipeline, featuring several promising candidates: Pimavanserin: This compound is currently undergoing Phase 3 clinical trials for additional indications, specifically for Alzheimer's disease psychosis and the negative symptoms of schizophrenia. Trofinetide: A novel synthetic compound, Trofinetide is also in Phase 3 development, aimed at treating Rett syndrome. ACP-044: This orally administered, first-in-class non-opioid analgesic is progressing through Phase 2 studies for both acute and chronic pain. ACP-319: Identified as a positive allosteric modulator of the muscarinic receptor, ACP-319 is in Phase 1 development, exploring its potential for schizophrenia and improving cognition in Alzheimer's patients. Established in 1993, ACADIA Pharmaceuticals Inc. is headquartered in San Diego, California.
News Sentiment (7d)
Based on only 2 articles — low confidence
- Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer Business Wire
- RPRX or ACAD: Which Is the Better Value Stock Right Now? Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD25.99
+0.50 (+1.96%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.83
Float Shares
168.66M
Free Float %
98.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.37% | -3.17% | +1.21% | -1.41% | -8.12% | -18.68% | +26.28% | -1.81% | +2.36% | -22.73% | +224.18% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (37 ratings, all time)
Buy
Price Targets & DCF
Current price
25.99
Low
29.00
+11.6%
Consensus
34.78
+33.8%
Median
35.00
+34.7%
High
40.00
+53.9%
Ratings Trend (MoM)
76% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 12 | 0 |
| Hold | 4 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 3 |
32.33
+24.4%
|
| Last Year | 19 |
32.32
+24.4%
|
| All Time | 60 |
28.43
+9.4%
|
Quality scores
Altman Z-Score
6.20
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✓ MOAT relativo
-
Revenue growth Biotechnology: +1.6%+11.9% ★ Q1'26: +9.7% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+68.4% ★ Q1'26: -81.8% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%+28.1% ★ Q1'26: +10.7% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+13.0% ★ Q1'26: -1.7% (vs Q1'25)
-
ROIC Biotechnology: -16.1%+30.2% ★ Q1'26: -3.8% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+3.0% ★ Q1'26: +3.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.38× ★ Q1'26: -2.75× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 16 Rev. Ana. 13 EPS Ana. |
Dec 2027 16 Rev. Ana. 13 EPS Ana. |
Dec 2028 17 Rev. Ana. 15 EPS Ana. |
Dec 2029 14 Rev. Ana. 10 EPS Ana. |
Dec 2030 8 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.15M
est: 1.06M (+7.7%)
|
120.0K
est: 102.5K (+17.1%)
|
61.0K
est: 969.6K (-93.7%)
|
17.33M
est: 14.41M (+20.2%)
|
124.90M
est: 126.57M (-1.3%)
|
223.81M
est: 223.73M (+0.0%)
|
339.08M
est: 337.54M (+0.5%)
|
441.76M
est: 443.75M (-0.4%)
|
484.15M
est: 487.98M (-0.8%)
|
517.24M
est: 514.79M (+0.5%)
|
726.44M
est: 813.81M (-10.7%)
|
957.80M
est: 968.63M (-1.1%)
|
1.07B
est: 1.08B (-0.9%)
|
1.24B
1.19B – 1.25B
+14.8% YoY
|
1.39B
1.32B – 1.47B
+12.0% YoY
|
1.57B
1.57B – 1.57B
+12.7% YoY
|
1.65B
1.58B – 1.70B
+5.1% YoY
|
1.80B
1.73B – 1.87B
+9.4% YoY
|
| EBITDA |
-38.22M
est: -35.89M (-6.5%)
|
-93.02M
est: -76.08M (-22.3%)
|
-163.47M
est: -131.68M (-24.1%)
|
-270.99M
est: -238.09M (-13.8%)
|
-289.70M
est: -316.58M (+8.5%)
|
-244.44M
est: -257.49M (+5.1%)
|
-243.78M
est: -239.54M (-1.8%)
|
-283.65M
est: -247.56M (-14.6%)
|
-167.10M
est: -182.78M (+8.6%)
|
-221.57M
est: -246.85M (+10.2%)
|
-67.83M
est: -102.97M (+34.1%)
|
100.16M
est: -122.56M (+181.7%)
|
138.90M
est: -136.76M (+201.6%)
|
-157.06M
-158.32M – -150.49M
-14.8% YoY
|
-175.87M
-185.99M – -167.02M
-12.0% YoY
|
-198.24M
-198.25M – -198.24M
-12.7% YoY
|
-208.31M
-215.73M – -199.60M
-5.1% YoY
|
-227.91M
-236.03M – -218.38M
-9.4% YoY
|
| EBIT |
-38.30M
est: -36.26M (-5.6%)
|
-93.23M
est: -76.87M (-21.3%)
|
-164.61M
est: -132.59M (-24.2%)
|
-272.82M
est: -242.21M (-12.6%)
|
-292.41M
est: -322.97M (+9.5%)
|
-247.44M
est: -264.43M (+6.4%)
|
-246.55M
est: -259.25M (+4.9%)
|
-286.59M
est: -262.76M (-9.1%)
|
-170.44M
est: -190.56M (+10.6%)
|
-223.60M
est: -254.56M (+12.2%)
|
-73.38M
est: -108.68M (+32.5%)
|
84.28M
est: -129.35M (+165.2%)
|
138.90M
est: -144.33M (+196.2%)
|
-165.76M
-167.09M – -158.83M
-14.8% YoY
|
-185.62M
-196.30M – -176.27M
-12.0% YoY
|
-209.23M
-209.23M – -209.23M
-12.7% YoY
|
-219.85M
-227.68M – -210.66M
-5.1% YoY
|
-240.54M
-249.10M – -230.48M
-9.4% YoY
|
| Net Income |
-37.95M
est: -35.93M (-5.6%)
|
-92.48M
est: -76.25M (-21.3%)
|
-164.44M
est: -132.48M (-24.1%)
|
-271.39M
est: -241.07M (-12.6%)
|
-289.40M
est: -319.56M (+9.4%)
|
-245.19M
est: -262.14M (+6.5%)
|
-235.26M
est: -246.81M (+4.7%)
|
-281.58M
est: -257.72M (-9.3%)
|
-167.87M
est: -187.72M (+10.6%)
|
-215.98M
est: -252.14M (+14.3%)
|
-61.29M
est: -1.71M (-3,484.0%)
|
226.45M
est: 138.60M (+63.4%)
|
391.00M
est: 137.80M (+183.7%)
|
63.16M
37.04M – 107.90M
-54.2% YoY
|
131.19M
1.57M – 266.17M
+107.7% YoY
|
266.83M
40.31M – 483.73M
+103.4% YoY
|
300.43M
284.10M – 314.34M
+12.6% YoY
|
406.60M
384.50M – 425.43M
+35.3% YoY
|
| SGA |
12.72M
est: 738.9K (+1,621.6%)
|
32.75M
est: 71.2K (+45,875.0%)
|
90.80M
est: 673.9K (+13,374.0%)
|
186.46M
est: 10.02M (+1,761.1%)
|
255.06M
est: 87.98M (+189.9%)
|
265.76M
est: 155.51M (+70.9%)
|
325.64M
est: 234.62M (+38.8%)
|
388.66M
est: 385.34M (+0.9%)
|
396.03M
est: 455.53M (-13.1%)
|
369.09M
est: 466.10M (-20.8%)
|
402.47M
est: 505.83M (-20.4%)
|
488.43M
est: 602.07M (-18.9%)
|
548.89M
est: 671.78M (-18.3%)
|
771.50M
739.24M – 777.72M
+14.8% YoY
|
863.93M
820.42M – 913.65M
+12.0% YoY
|
973.82M
973.82M – 973.83M
+12.7% YoY
|
1.02B
980.47M – 1.06B
+5.1% YoY
|
1.12B
1.07B – 1.16B
+9.4% YoY
|
| EPS |
-0.44
est: -0.40 (-10.0%)
|
-0.95
est: -0.67 (-42.9%)
|
-1.63
est: -1.58 (-2.9%)
|
-2.34
est: -2.34 (+0.1%)
|
-2.36
est: -2.40 (+1.5%)
|
-1.94
est: -1.99 (+2.6%)
|
-1.60
est: -1.62 (+1.1%)
|
-1.79
est: -1.84 (+2.7%)
|
-1.05
est: -1.02 (-3.0%)
|
-1.34
est: -1.32 (-1.9%)
|
-0.37
est: -0.01 (-3,458.4%)
|
1.37
est: 0.72 (+90.0%)
|
2.32
est: 0.81 (+186.7%)
|
0.39
0.22 – 0.63
-51.2% YoY
|
0.78
0.01 – 1.55
+96.8% YoY
|
1.45
0.24 – 2.82
+86.3% YoY
|
1.75
1.66 – 1.83
+21.1% YoY
|
2.37
2.24 – 2.48
+35.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-01 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
114.15M
OE per share TTM
0.67
Owner's Yield
3.12%
Maintenance CapEx ratio
0.76%
Maint CapEx / Avg PPE
7.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
79
Total invested
104.43M
Insider transactions (90d)
4
Beneficial owners (>5%)
21
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 13-4093645 | 23.11M | 20.80% | 23.11M | — | 23.11M | — | IA, PN | Delaware | 2016-01-08 | ↗ |
| 2 | 46-3147749 | 23.11M | 20.80% | 23.11M | — | 23.11M | — | HC, OO | Delaware | 2016-01-08 | ↗ |
| 3 | Felix J. Baker | 23.11M | 20.80% | 23.11M | — | 23.11M | — | HC, IN | United States | 2016-01-08 | ↗ |
| 4 | Julian C. Baker | 23.11M | 20.80% | 23.11M | — | 23.11M | — | HC, IN | United States | 2016-01-08 | ↗ |
| 5 | Abigail P. Johnson | 21.54M | 15.00% | — | — | 21.54M | — | IN | Delaware | 2019-02-13 | ↗ |
| 6 | FMR LLC | 21.54M | 15.00% | 5.56M | — | 21.54M | — | HC | Delaware | 2019-02-13 | ↗ |
| 7 | The Vanguard Group - 23-1945930 | 12.32M | 7.66% | — | 226.1K | 11.99M | 329.1K | IA | Pennsylvania | 2022-02-09 | ↗ |
| 8 | RTW Investments, LP | 11.25M | 6.90% | — | 11.25M | — | — | IA, PN | Delaware | 2024-02-14 | ↗ |
| 9 | Roderick Wong, M.D. | 11.25M | 6.90% | — | 11.25M | — | — | HC, IN | United States | 2024-02-14 | ↗ |
| 10 | (1) BlackRock, Inc. | 10.06M | 6.30% | 9.84M | — | 10.06M | — | HC | Delaware | 2022-02-04 | ↗ |
| 11 | 52-0556948 | 9.49M | 5.90% | 2.86M | — | 9.49M | — | IA | Maryland | 2022-02-14 | ↗ |
| 12 | Fidelity Growth Company Fund | 7.19M | 5.01% | 7.19M | — | — | — | IV | Delaware | 2019-02-13 | ↗ |
| 13 | Janus Henderson Group plc | 6.78M | 5.50% | — | 6.78M | — | 6.78M | IA, HC | Jersey, Channel Islands | 2018-02-12 | ↗ |
| 14 | Steven A. Cohen | 6.52M | 4.00% | — | 6.52M | — | 6.52M | IN | Citizenship or place of organization United States | 2018-06-18 | ↗ |
| 15 | Point72 Capital Advisors, Inc. | 6.34M | 4.00% | — | 6.34M | — | 6.34M | CO | Citizenship or place of organization Delaware | 2018-06-18 | ↗ |
| 16 | Point72 Asset Management, L.P. | 2.25M | 4.00% | — | 2.25M | — | 2.25M | PN | Delaware | 2019-02-14 | ↗ |
| 17 | Cubist Systematic Strategies, LLC | 175.5K | 4.00% | — | 175.5K | — | 175.5K | OO | Citizenship or place of organization Delaware | 2018-06-18 | ↗ |
| 18 | Point72 Hong Kong Limited | 1.5K | 4.00% | — | 1.5K | — | 1.5K | OO | Citizenship or place of organization Hong Kong | 2018-06-18 | ↗ |
| 19 | Peter Kolchinsky | — | 0.00% | — | — | — | — | IN | Citizenship or Place of Organization United States | 2016-02-16 | ↗ |
| 20 | RA Capital Healthcare Fund, L.P. | — | 0.00% | — | — | — | — | PN | Citizenship or Place of Organization Delaware | 2016-02-16 | ↗ |
| 21 | RA Capital Management, LLC | — | 0.00% | — | — | — | — | IA | Citizenship or Place of Organization Massachusetts | 2016-02-16 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
79
-269 vs prev Q
New positions
10
Closed positions
266
Increased
33
Reduced
28
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 1.42M +1.4M (+100.0%) | 37.91B +37.9B (+100.0%) | 0.84% +0.841 pp | 9.37% +9.367 pp | USD26.71 +0.0% | 1 qtrs NEW |
| 2 | BAKER BROS. ADVISORS LP | 42.90M +— (+0.0%) | 1.15B +230.4M (+25.2%) | 25.41% -0.153 pp | 6.71% +0.094 pp | USD15.77 +69.4% | 61 qtrs — |
| 3 | BLACKROCK, INC. | 20.76M +486.8K (+2.4%) | 554.38M +121.8M (+28.2%) | 12.29% +0.216 pp | 0.01% +0.002 pp | USD16.13 +65.6% | 6 qtrs — |
| 4 | VANGUARD GROUP INC | 15.15M -25.4K (-0.2%) | 404.76M +80.8M (+25.0%) | 8.98% -0.069 pp | 0.01% +0.001 pp | USD23.03 +16.0% | 84 qtrs — |
| 5 | STATE STREET CORP | 7.91M +655.3K (+9.0%) | 211.30M +56.5M (+36.5%) | 4.69% +0.362 pp | 0.01% +0.002 pp | USD20.91 +27.7% | 51 qtrs — |
| 6 | RTW INVESTMENTS, LP | 7.14M +— (+0.0%) | 190.83M +38.4M (+25.2%) | 4.23% -0.025 pp | 1.91% +0.033 pp | USD18.47 +44.6% | 15 qtrs — |
| 7 | POINT72 ASSET MANAGEMENT, L.P. | 3.38M +1.9M (+127.2%) | 90.21M +58.5M (+184.4%) | 2.00% +1.115 pp | 0.10% +0.048 pp | USD22.63 +18.0% | 13 qtrs — |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 3.24M +106.8K (+3.4%) | 86.54M +19.7M (+29.4%) | 1.92% +0.052 pp | 0.01% +0.001 pp | USD24.23 +10.2% | 78 qtrs — |
| 9 | DIMENSIONAL FUND ADVISORS LP | 2.92M +122.8K (+4.4%) | 78.02M +18.3M (+30.7%) | 1.73% +0.063 pp | 0.02% +0.004 pp | USD18.88 +41.5% | 26 qtrs — |
| 10 | PALO ALTO INVESTORS LP | 2.48M +17.3K (+0.7%) | 66.35M +13.7M (+26.0%) | 1.47% +0.002 pp | 9.24% -0.505 pp | USD27.63 -3.3% | 40 qtrs — |
| 11 | FIRST TRUST ADVISORS LP | 2.27M +326.9K (+16.8%) | 60.63M +19.2M (+46.2%) | 1.34% +0.187 pp | 0.04% +0.013 pp | USD21.89 +22.0% | 39 qtrs — |
| 12 | BRAIDWELL LP | 2.03M -346.6K (-14.6%) | 54.28M +3.5M (+6.9%) | 1.20% -0.214 pp | 1.74% +0.230 pp | USD21.34 +25.2% | 2 qtrs — |
| 13 | GOLDMAN SACHS GROUP INC | 1.57M -532.4K (-25.3%) | 41.94M -2.9M (-6.5%) | 0.93% -0.323 pp | 0.01% 0.000 pp | USD19.49 +37.0% | 53 qtrs — |
| 14 | FRED ALGER MANAGEMENT, LLC | 1.56M -7.1K (-0.5%) | 41.67M +8.2M (+24.6%) | 0.92% -0.010 pp | 0.16% +0.033 pp | USD24.73 +8.0% | 51 qtrs — |
| 15 | PICTET ASSET MANAGEMENT HOLDING SA | 1.55M +84.1K (+5.7%) | 41.49M +10.3M (+32.9%) | 0.92% +0.045 pp | 0.04% +0.010 pp | USD21.86 +22.2% | 10 qtrs — |
| 16 | RENAISSANCE TECHNOLOGIES LLC | 1.53M +83.1K (+5.7%) | 40.94M +10.0M (+32.3%) | 0.91% +0.044 pp | 0.06% +0.023 pp | USD19.68 +35.7% | 16 qtrs — |
| 17 | NORGES BANK | 1.51M +1.5M (+100.0%) | 40.27M +40.3M (+100.0%) | 0.89% +0.893 pp | 0.00% +0.004 pp | USD26.71 +0.0% | 1 qtrs NEW |
| 18 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.50M -146.2K (-8.9%) | 40.13M +4.9M (+14.1%) | 0.89% -0.093 pp | 0.02% +0.001 pp | USD21.39 +24.9% | 3 qtrs — |
| 19 | CITADEL ADVISORS LLC | 1.37M +1.0M (+322.7%) | 36.52M +29.6M (+429.0%) | 0.81% +0.617 pp | 0.01% +0.004 pp | USD25.45 +5.0% | 52 qtrs — |
| 20 | FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.30M +683.4K (+111.3%) | 34.65M +21.5M (+164.5%) | 0.77% +0.403 pp | 0.93% +0.538 pp | USD24.17 +10.5% | 14 qtrs — |
| 21 | NORTHERN TRUST CORP | 1.24M -67.7K (-5.2%) | 33.01M +5.2M (+18.7%) | 0.73% -0.045 pp | 0.00% +0.001 pp | USD21.82 +22.4% | 51 qtrs — |
| 22 | BANK OF AMERICA CORP /DE/ | 1.22M +333.6K (+37.6%) | 32.62M +13.7M (+72.2%) | 0.72% +0.194 pp | 0.00% +0.001 pp | USD21.21 +25.9% | 52 qtrs — |
| 23 | QUBE RESEARCH & TECHNOLOGIES LTD | 1.20M +606.2K (+101.6%) | 32.12M +19.4M (+152.4%) | 0.71% +0.357 pp | 0.03% +0.020 pp | USD22.91 +16.6% | 13 qtrs — |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.17M -31.8K (-2.6%) | 31.31M +5.6M (+21.9%) | 0.69% -0.023 pp | 0.00% +0.001 pp | USD26.21 +1.9% | 52 qtrs — |
| 25 | MORGAN STANLEY | 1.14M -46.4K (-3.9%) | 30.50M +5.1M (+20.3%) | 0.68% -0.032 pp | 0.00% +0.000 pp | USD18.24 +46.4% | 51 qtrs — |
| 26 | TWO SIGMA INVESTMENTS, LP | 1.12M +453.2K (+68.1%) | 29.89M +15.7M (+110.4%) | 0.66% +0.266 pp | 0.04% +0.021 pp | USD21.67 +23.3% | 19 qtrs — |
| 27 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 1.11M +76.7K (+7.4%) | 29.73M +7.6M (+34.4%) | 0.66% +0.042 pp | 0.05% +0.010 pp | USD19.63 +36.1% | 23 qtrs — |
| 28 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.07M -38.2K (-3.4%) | 28.65M +4.9M (+20.9%) | 0.64% -0.027 pp | 0.01% +0.002 pp | USD21.83 +22.4% | 9 qtrs — |
| 29 | NUVEEN, LLC | 1.06M +103.5K (+10.9%) | 28.25M +7.9M (+38.7%) | 0.63% +0.058 pp | 0.01% +0.002 pp | USD18.10 +47.6% | 4 qtrs — |
| 30 | D. E. SHAW & CO., INC. | 1.03M -534.4K (-34.2%) | 27.43M -5.9M (-17.7%) | 0.61% -0.322 pp | 0.02% -0.004 pp | USD23.59 +13.2% | 31 qtrs — |
| 31 | LOGOS GLOBAL MANAGEMENT LP | 850.0K +850.0K (+100.0%) | 22.70M +22.7M (+100.0%) | 0.50% +0.503 pp | 1.37% +1.372 pp | USD26.71 +0.0% | 1 qtrs NEW |
| 32 | INVESCO LTD. | 848.0K +107.4K (+14.5%) | 22.65M +6.8M (+43.3%) | 0.50% +0.061 pp | 0.00% +0.001 pp | USD18.77 +42.3% | 51 qtrs — |
| 33 | DEUTSCHE BANK AG\ | 828.6K -693.6K (-45.6%) | 22.13M -10.4M (-31.9%) | 0.49% -0.416 pp | 0.01% -0.004 pp | USD23.32 +14.5% | 50 qtrs — |
| 34 | EMERALD ADVISERS, LLC | 811.2K +241.5K (+42.4%) | 21.67M +9.5M (+78.2%) | 0.48% +0.141 pp | 0.67% +0.278 pp | USD22.27 +19.9% | 17 qtrs — |
| 35 | UBS GROUP AG | 769.4K +104.5K (+15.7%) | 20.55M +6.4M (+44.8%) | 0.46% +0.060 pp | 0.00% +0.001 pp | USD20.26 +31.8% | 45 qtrs — |
| 36 | BANK OF NEW YORK MELLON CORP | 752.0K -43.9K (-5.5%) | 20.09M +3.1M (+18.3%) | 0.45% -0.029 pp | 0.00% +0.000 pp | USD21.49 +24.3% | 66 qtrs — |
| 37 | PRINCIPAL FINANCIAL GROUP INC | 745.4K +48.8K (+7.0%) | 19.91M +5.0M (+33.9%) | 0.44% +0.026 pp | 0.01% +0.003 pp | USD17.65 +51.3% | 51 qtrs — |
| 38 | FMR LLC | 727.0K +61.2K (+9.2%) | 19.42M +5.2M (+36.7%) | 0.43% +0.034 pp | 0.00% +0.000 pp | USD20.64 +29.4% | 70 qtrs — |
| 39 | PANAGORA ASSET MANAGEMENT INC | 681.1K +24.3K (+3.7%) | 18.19M +4.2M (+29.8%) | 0.40% +0.012 pp | 0.06% +0.008 pp | USD21.22 +25.9% | 20 qtrs — |
| 40 | FISHER ASSET MANAGEMENT, LLC | 665.1K +26.6K (+4.2%) | 17.76M +4.1M (+30.4%) | 0.39% +0.014 pp | 0.01% +0.001 pp | USD22.38 +19.3% | 9 qtrs — |
| 41 | AMERIPRISE FINANCIAL INC | 662.2K -22.6K (-3.3%) | 17.68M +3.1M (+21.0%) | 0.39% -0.016 pp | 0.00% +0.001 pp | USD27.45 -2.7% | 53 qtrs — |
| 42 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 658.8K +133.4K (+25.4%) | 17.32M +6.2M (+55.2%) | 0.39% +0.077 pp | 0.03% +0.010 pp | USD20.38 +31.1% | 17 qtrs — |
| 43 | VOYA INVESTMENT MANAGEMENT LLC | 641.5K -44.0K (-6.4%) | 17.13M +2.5M (+17.1%) | 0.38% -0.029 pp | 0.02% +0.002 pp | USD21.21 +25.9% | 51 qtrs — |
| 44 | JUPITER ASSET MANAGEMENT LTD | 621.0K +144.7K (+30.4%) | 16.59M +6.4M (+63.2%) | 0.37% +0.084 pp | 0.13% +0.046 pp | USD20.33 +31.4% | 15 qtrs — |
| 45 | PRICE T ROWE ASSOCIATES INC /MD/ | 615.2K -485.7K (-44.1%) | 16.43M -7.1M (-30.1%) | 0.36% -0.292 pp | 0.00% -0.001 pp | USD23.77 +12.4% | 53 qtrs — |
| 46 | ALGERT GLOBAL LLC | 614.4K +214.3K (+53.6%) | 16.41M +7.9M (+92.2%) | 0.36% +0.126 pp | 0.26% +0.113 pp | USD23.20 +15.1% | 18 qtrs — |
| 47 | AQR CAPITAL MANAGEMENT LLC | 604.7K -16.1K (-2.6%) | 16.15M +2.9M (+21.9%) | 0.36% -0.012 pp | 0.01% +0.000 pp | USD21.28 +25.5% | 17 qtrs — |
| 48 | RICE HALL JAMES & ASSOCIATES, LLC | 603.7K -11.2K (-1.8%) | 16.13M +3.0M (+22.9%) | 0.36% -0.009 pp | 0.89% +0.172 pp | USD23.12 +15.5% | 24 qtrs — |
| 49 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 581.0K -87.4K (-13.1%) | 15.52M +1.3M (+8.8%) | 0.34% -0.054 pp | 0.04% -0.004 pp | USD17.97 +48.6% | 16 qtrs — |
| 50 | MILLENNIUM MANAGEMENT LLC | 553.7K -929.6K (-62.7%) | 14.79M -16.9M (-53.3%) | 0.33% -0.556 pp | 0.01% -0.007 pp | USD21.23 +25.8% | 54 qtrs — |
| 51 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 532.5K -1.6K (-0.3%) | 14.22M +2.8M (+24.8%) | 0.32% -0.003 pp | 0.01% +0.002 pp | USD22.03 +21.2% | 21 qtrs — |
| 52 | MARSHALL WACE, LLP | 493.4K -1.9M (-79.1%) | 13.18M -37.2M (-73.8%) | 0.29% -1.113 pp | 0.01% -0.039 pp | USD20.82 +28.3% | 11 qtrs — |
| 53 | PRUDENTIAL FINANCIAL INC | 485.9K -423.5K (-46.6%) | 12.98M -6.4M (-33.1%) | 0.29% -0.254 pp | 0.02% -0.007 pp | USD20.07 +33.1% | 53 qtrs — |
| 54 | EMERALD MUTUAL FUND ADVISERS TRUST | 484.5K +169.2K (+53.7%) | 12.94M +6.2M (+92.3%) | 0.29% +0.099 pp | 0.63% +0.283 pp | USD22.55 +18.4% | 17 qtrs — |
| 55 | GLENMEDE TRUST CO NA | 453.6K +453.6K (+100.0%) | 12.12M +12.1M (+100.0%) | 0.27% +0.269 pp | 0.06% +0.057 pp | USD26.71 +0.0% | 1 qtrs NEW |
| 56 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 433.2K -53.7K (-11.0%) | 11.57M +1.2M (+11.4%) | 0.26% -0.034 pp | 0.04% +0.001 pp | USD17.56 +52.1% | 4 qtrs — |
| 57 | JACOBS LEVY EQUITY MANAGEMENT, INC | 371.0K -371.0K (-50.0%) | 9.91M -5.9M (-37.4%) | 0.22% -0.222 pp | 0.04% -0.025 pp | USD16.28 +64.1% | 20 qtrs — |
| 58 | TWO SIGMA ADVISERS, LP | 370.2K +271.8K (+276.2%) | 9.89M +7.8M (+370.9%) | 0.22% +0.161 pp | 0.02% +0.015 pp | USD24.25 +10.1% | 12 qtrs — |
| 59 | BARCLAYS PLC | 368.3K +90.7K (+32.7%) | 9.84M +5.6M (+130.4%) | 0.22% +0.053 pp | 0.00% +0.001 pp | USD21.74 +22.9% | 51 qtrs — |
| 60 | RHUMBLINE ADVISERS | 361.1K -30.5K (-7.8%) | 9.64M +1.3M (+15.4%) | 0.21% -0.019 pp | 0.01% +0.001 pp | USD19.70 +35.6% | 51 qtrs — |
| 61 | MAN GROUP PLC | 348.2K -29.0K (-7.7%) | 9.30M +1.3M (+15.5%) | 0.21% -0.019 pp | 0.02% +0.002 pp | USD18.32 +45.8% | 16 qtrs — |
| 62 | EDGESTREAM PARTNERS, L.P. | 316.2K +82.4K (+35.2%) | 8.45M +3.5M (+69.3%) | 0.19% +0.048 pp | 0.24% +0.092 pp | USD21.65 +23.4% | 11 qtrs — |
| 63 | LEGAL & GENERAL GROUP PLC | 314.4K -20.4K (-6.1%) | 8.40M +1.3M (+17.5%) | 0.19% -0.013 pp | 0.00% +0.000 pp | USD22.29 +19.8% | 46 qtrs — |
| 64 | GREAT LAKES ADVISORS, LLC | 313.5K -141.3K (-31.1%) | 8.37M -1.3M (-13.7%) | 0.19% -0.085 pp | 0.07% -0.013 pp | USD18.91 +41.2% | 5 qtrs — |
| 65 | TANG CAPITAL MANAGEMENT LLC | 300.0K -1.2M (-80.0%) | 8.01M -24.0M (-75.0%) | 0.18% -0.716 pp | 0.40% -0.836 pp | USD17.11 +56.1% | 10 qtrs — |
| 66 | TREXQUANT INVESTMENT LP | 297.8K +69.7K (+30.6%) | 7.95M +3.1M (+63.4%) | 0.18% +0.041 pp | 0.07% +0.021 pp | USD21.57 +23.8% | 32 qtrs — |
| 67 | ALLIANZ ASSET MANAGEMENT GMBH | 295.5K +263.6K (+827.0%) | 7.89M +7.2M (+1,060.3%) | 0.18% +0.156 pp | 0.01% +0.007 pp | USD25.83 +3.4% | 6 qtrs — |
| 68 | ROYAL BANK OF CANADA | 290.9K -609.6K (-67.7%) | 7.77M -11.4M (-59.6%) | 0.17% -0.364 pp | 0.00% -0.002 pp | USD21.45 +24.5% | 51 qtrs — |
| 69 | JANUS HENDERSON GROUP PLC | 290.1K +238.7K (+464.3%) | 7.75M +6.7M (+606.6%) | 0.17% +0.141 pp | 0.00% +0.003 pp | USD25.28 +5.7% | 26 qtrs — |
| 70 | JPMORGAN CHASE & CO | 270.8K -55.1K (-16.9%) | 7.23M +278.6K (+4.0%) | 0.16% -0.034 pp | 0.00% +0.000 pp | USD21.46 +24.5% | 51 qtrs — |
| 71 | NORDEA INVESTMENT MANAGEMENT AB | 237.6K -42.7K (-15.2%) | 6.35M +438.6K (+7.4%) | 0.14% -0.026 pp | 0.01% +0.000 pp | USD22.09 +20.9% | 20 qtrs — |
| 72 | SWISS NATIONAL BANK | 232.9K +5.8K (+2.6%) | 6.22M +1.4M (+28.4%) | 0.14% +0.003 pp | 0.00% +0.001 pp | USD27.77 -3.8% | 51 qtrs — |
| 73 | LAZARD ASSET MANAGEMENT LLC | 226.2K +53.4K (+30.9%) | 6.04M +2.4M (+63.8%) | 0.13% +0.031 pp | 0.01% +0.005 pp | USD21.94 +21.7% | 14 qtrs — |
| 74 | F/M INVESTMENTS LLC | 224.0K +173.4K (+342.9%) | 5.98M +4.9M (+454.3%) | 0.13% +0.103 pp | 0.23% +0.186 pp | USD24.83 +7.6% | 5 qtrs — |
| 75 | SPHERA FUNDS MANAGEMENT LTD. | 212.2K +63.3K (+42.5%) | 5.67M +2.5M (+78.4%) | 0.13% +0.037 pp | 1.10% +0.425 pp | USD23.10 +15.6% | 8 qtrs — |
| 76 | WELLS FARGO & COMPANY/MN | 209.2K +58.4K (+38.7%) | 5.59M +2.4M (+73.6%) | 0.12% +0.034 pp | 0.00% +0.000 pp | USD21.18 +26.1% | 57 qtrs — |
| 77 | UBS ASSET MANAGEMENT AMERICAS INC | 205.4K -5.7K (-2.7%) | 5.49M +981.9K (+21.8%) | 0.12% -0.004 pp | 0.00% +0.000 pp | USD18.73 +42.6% | 51 qtrs — |
| 78 | RAFFERTY ASSET MANAGEMENT, LLC | 198.3K +3.2K (+1.7%) | 5.30M +1.1M (+27.2%) | 0.12% +0.001 pp | 0.02% +0.005 pp | USD20.70 +29.0% | 28 qtrs — |
| 79 | DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 194.1K +123.1K (+173.3%) | 5.19M +3.7M (+242.1%) | 0.12% +0.073 pp | 0.00% +0.003 pp | USD24.75 +7.9% | 2 qtrs — |
| 80 | VICTORY CAPITAL MANAGEMENT INC | 177.6K -63.5K (-26.3%) | 4.74M -400.6K (-7.8%) | 0.11% -0.038 pp | 0.00% 0.000 pp | USD20.20 +32.2% | 26 qtrs — |
| 81 | EVERSEPT PARTNERS, LP | 176.6K +12.4K (+7.5%) | 4.72M +1.2M (+34.6%) | 0.10% +0.007 pp | 0.24% -0.004 pp | USD21.72 +23.0% | 2 qtrs — |
| 82 | FRANKLIN RESOURCES INC | 171.5K -207.0K (-54.7%) | 4.58M -2.4M (-34.6%) | 0.10% -0.124 pp | 0.00% -0.001 pp | USD20.22 +32.1% | 29 qtrs — |
| 83 | BIRCHVIEW CAPITAL, LP | 171.0K +— (+0.0%) | 4.57M +918.3K (+25.2%) | 0.10% -0.001 pp | 2.67% -0.081 pp | USD23.83 +12.1% | 27 qtrs — |
| 84 | ALPS ADVISORS INC | 158.2K +58.4K (+58.5%) | 4.23M +2.1M (+98.4%) | 0.09% +0.034 pp | 0.02% +0.013 pp | USD23.49 +13.7% | 19 qtrs — |
| 85 | ALLIANCEBERNSTEIN L.P. | 156.2K +1.3K (+0.8%) | 4.17M +865.7K (+26.2%) | 0.09% +0.000 pp | 0.00% +0.000 pp | USD21.68 +23.2% | 51 qtrs — |
| 86 | SEI INVESTMENTS CO | 154.1K +56.1K (+57.2%) | 4.12M +2.0M (+96.8%) | 0.09% +0.033 pp | 0.00% +0.002 pp | USD22.68 +17.8% | 45 qtrs — |
| 87 | ENVESTNET ASSET MANAGEMENT INC | 152.2K +2.5K (+1.7%) | 4.06M +870.9K (+27.3%) | 0.09% +0.001 pp | 0.00% +0.000 pp | USD21.41 +24.8% | 26 qtrs — |
| 88 | STATE OF WISCONSIN INVESTMENT BOARD | 150.4K -38.8K (-20.5%) | 4.02M -20.7K (-0.5%) | 0.09% -0.024 pp | 0.01% 0.000 pp | USD21.59 +23.7% | 39 qtrs — |
| 89 | HUSSMAN STRATEGIC ADVISORS, INC. | 147.0K +21.0K (+16.7%) | 3.93M +1.2M (+46.0%) | 0.09% +0.012 pp | 0.95% +0.367 pp | USD22.11 +20.8% | 2 qtrs — |
| 90 | RUSSELL INVESTMENTS GROUP, LTD. | 138.3K +59.3K (+75.1%) | 3.69M +2.0M (+119.2%) | 0.08% +0.035 pp | 0.00% +0.002 pp | USD21.88 +22.1% | 37 qtrs — |
| 91 | BRIDGEWATER ASSOCIATES, LP | 138.2K -25.1K (-15.4%) | 3.69M +207.1K (+5.9%) | 0.08% -0.015 pp | 0.01% 0.000 pp | USD21.34 +25.2% | 2 qtrs — |
| 92 | AXECAP INVESTMENTS, LLC | 136.7K -66.7K (-32.8%) | 3.65M -689.3K (-15.9%) | 0.08% -0.040 pp | 2.25% -0.430 pp | USD21.34 +25.2% | 2 qtrs — |
| 93 | ERSTE ASSET MANAGEMENT GMBH | 133.7K +— (+0.0%) | 3.64M +794.2K (+27.9%) | 0.08% -0.001 pp | 0.03% +0.003 pp | USD25.16 +6.2% | 29 qtrs — |
| 94 | AMERICAN CENTURY COMPANIES INC | 129.0K -289.3K (-69.2%) | 3.45M -5.5M (-61.4%) | 0.08% -0.173 pp | 0.00% -0.003 pp | USD16.68 +60.1% | 11 qtrs — |
| 95 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 128.7K +— (+0.0%) | 3.44M +691.1K (+25.2%) | 0.08% -0.001 pp | 0.01% +0.001 pp | USD25.44 +5.0% | 51 qtrs — |
| 96 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 126.8K +26.1K (+25.9%) | 3.39M +1.2M (+57.6%) | 0.08% +0.015 pp | 0.00% +0.001 pp | USD27.62 -3.3% | 51 qtrs — |
| 97 | SEGALL BRYANT & HAMILL, LLC | 126.1K +126.1K (+100.0%) | 3.37M +3.4M (+100.0%) | 0.07% +0.075 pp | 0.05% +0.046 pp | USD26.71 +0.0% | 1 qtrs NEW |
| 98 | ACADIAN ASSET MANAGEMENT LLC | 119.7K +54.4K (+83.1%) | 3.20M +1.8M (+129.4%) | 0.07% +0.032 pp | 0.01% +0.003 pp | USD23.78 +12.3% | 2 qtrs — |
| 99 | MARTINGALE ASSET MANAGEMENT L P | 109.3K +9.0K (+9.0%) | 2.92M +778.9K (+36.4%) | 0.06% +0.005 pp | 0.07% +0.020 pp | USD21.93 +21.8% | 3 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 165 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco Biotechnology & Genome ETF PBE | 3.00% | 8.60M | 0.58% |
| 2 | ALPS Medical Breakthroughs ETF SBIO | 2.29% | 4.88M | 0.50% |
| 3 | Allspring SMID Core ETF ASCE | 1.75% | 1.38M | 0.38% |
| 4 | Virtus Biotech ETF BBP | 1.60% | 1.58M | 0.34% |
| 5 | Invesco S&P SmallCap Health Care ETF PSCH | 1.45% | 2.37M | 0.29% |
| 6 | Invesco S&P SmallCap 600 Revenue ETF RZG | 1.13% | 1.62M | 0.35% |
| 7 | Franklin Small Cap Enhanced ETF FSML | 1.12% | 1.66M | 0.45% |
| 8 | Global X - S&P Biotech ETF CURE.AX | 0.97% | 347.2K | 0.45% |
| 9 | State Street SPDR S&P Biotech ETF XBI | 0.97% | 104.56M | 0.35% |
| 10 | VictoryShares Small Cap Free Cash Flow ETF SFLO | 0.66% | 4.18M | 0.56% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.50
Neutral
Ratio by volume
0.66
Neutral
Buys
4
Sells
8
Shares acquired
16.7K
Shares disposed
25.3K
Cash buys
—
Cash sales
4.00
Net activity
-8,577
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 3,506 | 21.79 | 76.4K | 66,145 | D | ↗ |
| 2026-05-04 | Kihara James | Officer | S-Sale | D | Common Stock | 1,332 | 21.79 | 29.0K | 29,129 | D | ↗ |
| 2026-05-01 | Schneyer Mark C. | Officer | M-Exempt | A | Common Stock | 6,815 | 0.00 | — | 69,651 | D | ↗ |
| 2026-05-01 | Kihara James | Officer | M-Exempt | A | Common Stock | 2,596 | 0.00 | — | 30,461 | D | ↗ |
| 2026-04-07 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 2,709 | 22.20 | 60.1K | 62,836 | D | ↗ |
| 2026-04-07 | Kihara James | Officer | S-Sale | D | Common Stock | 1,030 | 22.20 | 22.9K | 27,865 | D | ↗ |
| 2026-04-05 | Schneyer Mark C. | Officer | M-Exempt | D | Restricted Stock Units | 5,276 | 0.00 | — | 0 | D | ↗ |
| 2026-04-05 | Kihara James | Officer | M-Exempt | D | Restricted Stock Units | 2,010 | 0.00 | — | 0 | D | ↗ |
| 2026-03-26 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 37 | 21.72 | 803.54 | 60,269 | D | ↗ |
| 2026-03-26 | Kihara James | Officer | S-Sale | D | Common Stock | 12 | 21.73 | 260.70 | 26,885 | D | ↗ |
| 2026-03-25 | Thompson Elizabeth H.Z. | Officer | S-Sale | D | Common Stock | 3,435 | 21.47 | 73.7K | 3,280 | D | ↗ |
| 2026-03-25 | Schneyer Mark C. | Officer | M-Exempt | A | Common Stock | 6,178 | 0.00 | — | 63,477 | D | ↗ |
| 2026-03-25 | Rhodes Jennifer J | Officer | S-Sale | D | Common Stock | 3,844 | 21.47 | 82.5K | 11,280 | D | ↗ |
| 2026-03-25 | Owen Adams Catherine | Director / Officer | S-Sale | D | Common Stock | 11,641 | 21.47 | 249.9K | 14,803 | D | ↗ |
| 2026-03-25 | Kihara James | Officer | M-Exempt | D | Restricted Stock Units | 2,142 | 0.00 | — | 4,284 | D | ↗ |
| 2026-03-24 | Thompson Elizabeth H.Z. | Officer | M-Exempt | A | Common Stock | 6,715 | 0.00 | — | 6,715 | D | ↗ |
| 2026-03-24 | Schneyer Mark C. | Officer | M-Exempt | D | Restricted Stock Units | 8,138 | 0.00 | — | 24,414 | D | ↗ |
| 2026-03-24 | Rhodes Jennifer J | Officer | M-Exempt | A | Common Stock | 7,515 | 0.00 | — | 15,124 | D | ↗ |
| 2026-03-24 | Owen Adams Catherine | Director / Officer | M-Exempt | A | Common Stock | 23,509 | 0.00 | — | 26,444 | D | ↗ |
| 2026-03-24 | Kihara James | Officer | M-Exempt | D | Restricted Stock Units | 1,627 | 0.00 | — | 4,883 | D | ↗ |
| 2026-03-06 | Thompson Elizabeth H.Z. | Officer | A-Award | A | Restricted Stock Units | 29,548 | 0.00 | — | 29,548 | D | ↗ |
| 2026-03-06 | Schneyer Mark C. | Officer | A-Award | A | Restricted Stock Units | 26,382 | 0.00 | — | 26,382 | D | ↗ |
| 2026-03-06 | Rhodes Jennifer J | Officer | A-Award | A | Restricted Stock Units | 26,382 | 0.00 | — | 26,382 | D | ↗ |
| 2026-03-06 | Owen Adams Catherine | Director / Officer | A-Award | A | Restricted Stock Units | 76,509 | 0.00 | — | 76,509 | D | ↗ |
| 2026-03-06 | Kihara James | Officer | A-Award | A | Restricted Stock Units | 6,332 | 0.00 | — | 6,332 | D | ↗ |
| 2026-03-06 | Garner Thomas | Officer | A-Award | A | Restricted Stock Units | 28,493 | 0.00 | — | 28,493 | D | ↗ |
| 2026-03-03 | Poole Jonathan | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-02-09 | Rhodes Jennifer J | Officer | S-Sale | D | Common Stock | 6,950 | 23.38 | 162.5K | 7,609 | D | ↗ |
| 2026-02-06 | Rhodes Jennifer J | Officer | M-Exempt | A | Common Stock | 12,944 | 0.00 | — | 14,559 | D | ↗ |
| 2025-11-18 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 10,262 | 23.69 | 243.1K | 53,338 | D | ↗ |
| 2025-11-18 | Kihara James | Officer | S-Sale | D | Common Stock | 4,084 | 23.69 | 96.8K | 25,058 | D | ↗ |
| 2025-11-17 | Schneyer Mark C. | Officer | M-Exempt | A | Common Stock | 9,913 | 0.00 | — | 53,687 | D | ↗ |
| 2025-11-17 | Kihara James | Officer | M-Exempt | A | Common Stock | 3,966 | 0.00 | — | 29,142 | D | ↗ |
| 2025-11-10 | Daly James M | Director | S-Sale | D | Common Stock | 30,000 | 22.37 | 671.0K | 4,041 | D | ↗ |
| 2025-09-15 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 3,498 | 23.65 | 82.7K | 43,447 | D | ↗ |
| 2025-09-12 | Schneyer Mark C. | Officer | A-Award | A | Common Stock | 6,815 | 0.00 | — | 46,945 | D | ↗ |
| 2025-09-02 | GAROFALO ELIZABETH A. | Director | S-Sale | D | Common Stock | 1,600 | 25.98 | 41.6K | 25,382 | D | ↗ |
| 2025-08-18 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 22,000 | 25.18 | 554.0K | 40,130 | D | ↗ |
| 2025-06-04 | Brege Laura | Director | S-Sale | D | Common Stock | 14,446 | 21.78 | 314.6K | 15,095 | D | ↗ |
| 2025-05-29 | SOLAND DANIEL B | Director | M-Exempt | D | Restricted Stock Units | 9,387 | 0.00 | — | 0 | D | ↗ |
| 2025-05-29 | Ndu Adora | Director | M-Exempt | D | Restricted Stock Units | 9,387 | 0.00 | — | 0 | D | ↗ |
| 2025-05-29 | HARRIGAN EDMUND | Director | A-Award | A | Restricted Stock Units | 8,107 | 0.00 | — | 8,107 | D | ↗ |
| 2025-05-29 | GAROFALO ELIZABETH A. | Director | M-Exempt | D | Restricted Stock Units | 9,387 | 0.00 | — | 0 | D | ↗ |
| 2025-05-29 | Daly James M | Director | M-Exempt | A | Common Stock | 9,387 | 0.00 | — | 34,041 | D | ↗ |
| 2025-05-29 | Brege Laura | Director | A-Award | A | Director Stock Options (Right to Buy) | 13,793 | 22.29 | 307.4K | 13,793 | D | ↗ |
| 2025-05-29 | BAKER BROS. ADVISORS LP | Director / 10% Owner | A-Award | A | Common Stock | 16,214 | 0.00 | — | 3,658,735 | I | ↗ |
| 2025-05-16 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 2,000 | 25.00 | 50.0K | 62,130 | D | ↗ |
| 2025-05-16 | Kihara James | Officer | S-Sale | D | Common Stock | 2,000 | 20.00 | 40.0K | 20,395 | D | ↗ |
| 2025-05-02 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 3,498 | 14.60 | 51.1K | 62,773 | D | ↗ |
| 2025-05-02 | Kihara James | Officer | S-Sale | D | Common Stock | 1,327 | 14.60 | 19.4K | 23,526 | D | ↗ |
| 2025-05-01 | Schneyer Mark C. | Officer | M-Exempt | A | Common Stock | 6,815 | 0.00 | — | 66,271 | D | ↗ |
| 2025-05-01 | Kihara James | Officer | M-Exempt | A | Common Stock | 2,596 | 0.00 | — | 24,853 | D | ↗ |
| 2025-04-08 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 2,708 | 14.82 | 40.1K | 59,456 | D | ↗ |
| 2025-04-08 | Kihara James | Officer | S-Sale | D | Common Stock | 1,028 | 14.82 | 15.2K | 22,257 | D | ↗ |
| 2025-04-05 | Schneyer Mark C. | Officer | M-Exempt | A | Common Stock | 5,275 | 0.00 | — | 62,164 | D | ↗ |
| 2025-04-05 | Kihara James | Officer | M-Exempt | A | Common Stock | 2,010 | 0.00 | — | 23,285 | D | ↗ |
| 2025-03-26 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 3,171 | 17.05 | 54.1K | 56,889 | D | ↗ |
| 2025-03-26 | Kihara James | Officer | S-Sale | D | Common Stock | 1,095 | 17.05 | 18.7K | 21,275 | D | ↗ |
| 2025-03-25 | Schneyer Mark C. | Officer | M-Exempt | A | Common Stock | 6,178 | 0.00 | — | 60,060 | D | ↗ |
| 2025-03-25 | Kihara James | Officer | M-Exempt | D | Restricted Stock Units | 2,142 | 0.00 | — | 6,426 | D | ↗ |
| 2025-03-24 | Thompson Elizabeth H.Z. | Officer | A-Award | A | Restricted Stock Units | 26,861 | 0.00 | — | 26,861 | D | ↗ |
| 2025-03-24 | Schneyer Mark C. | Officer | A-Award | A | Stock Option (Right to Buy) | 110,761 | 17.23 | 1.91M | 110,761 | D | ↗ |
| 2025-03-24 | Rhodes Jennifer J | Officer | A-Award | A | Restricted Stock Units | 30,062 | 0.00 | — | 30,062 | D | ↗ |
| 2025-03-24 | Owen Adams Catherine | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 319,976 | 17.23 | 5.51M | 319,976 | D | ↗ |
| 2025-03-24 | Kihara James | Officer | A-Award | A | Stock Option (Right to Buy) | 22,152 | 17.23 | 381.7K | 22,152 | D | ↗ |
| 2025-03-05 | GAROFALO ELIZABETH A. | Director | S-Sale | D | Common Stock | 4,919 | 18.23 | 89.7K | 17,595 | D | ↗ |
| 2025-02-24 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 773 | 19.96 | 15.4K | 53,882 | D | ↗ |
| 2025-02-24 | Kihara James | Officer | S-Sale | D | Common Stock | 475 | 19.96 | 9.5K | 20,228 | D | ↗ |
| 2025-02-23 | Schneyer Mark C. | Officer | M-Exempt | A | Common Stock | 1,353 | 0.00 | — | 54,655 | D | ↗ |
| 2025-02-23 | Kihara James | Officer | M-Exempt | A | Common Stock | 840 | 0.00 | — | 20,703 | D | ↗ |
| 2024-12-09 | Garner Thomas | Officer | A-Award | A | Stock Option (Right to Buy) | 235,849 | 18.76 | 4.42M | 235,849 | D | ↗ |
| 2024-11-19 | Teehan Brendan | Officer | S-Sale | D | Common Stock | 10,329 | 16.81 | 173.6K | 62,105 | D | ↗ |
| 2024-11-19 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 10,259 | 16.81 | 172.5K | 53,302 | D | ↗ |
| 2024-11-19 | Kihara James | Officer | S-Sale | D | Common Stock | 4,073 | 16.81 | 68.5K | 19,863 | D | ↗ |
| 2024-11-17 | Teehan Brendan | Officer | M-Exempt | A | Common Stock | 9,913 | 0.00 | — | 72,434 | D | ↗ |
| 2024-11-17 | Schneyer Mark C. | Officer | M-Exempt | D | Restricted Stock Units | 9,913 | 0.00 | — | 9,913 | D | ↗ |
| 2024-11-17 | Kihara James | Officer | M-Exempt | D | Restricted Stock Units | 3,965 | 0.00 | — | 3,966 | D | ↗ |
| 2024-10-12 | Ndu Adora | Director | M-Exempt | A | Common Stock | 4,381 | 0.00 | — | 15,414 | D | ↗ |
| 2024-09-23 | Adams Catherine Owen | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 353,261 | 16.29 | 5.75M | 353,261 | D | ↗ |
| 2024-08-19 | Teehan Brendan | Officer | S-Sale | D | Common Stock | 9,534 | 15.28 | 145.7K | 52,177 | — | ↗ |
| 2024-08-19 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 9,733 | 15.28 | 148.7K | 43,735 | — | ↗ |
| 2024-08-19 | DAVIS STEPHEN | Director / Officer | S-Sale | D | Common Stock | 31,747 | 15.28 | 485.1K | 186,555 | — | ↗ |
| 2024-08-16 | Teehan Brendan | Officer | A-Award | A | Common Stock | 5,024 | 0.00 | — | 48,082 | — | ↗ |
| 2024-08-16 | Schneyer Mark C. | Officer | A-Award | A | Common Stock | 5,275 | 0.00 | — | 39,839 | — | ↗ |
| 2024-08-16 | DAVIS STEPHEN | Director / Officer | A-Award | A | Common Stock | 17,333 | 0.00 | — | 173,520 | — | ↗ |
| 2024-08-12 | Thompson Elizabeth H.Z. | Officer | A-Award | A | Stock Option (Right to Buy) | 324,582 | 15.29 | 4.96M | 324,582 | — | ↗ |
| 2024-06-10 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 975 | 14.79 | 14.4K | 34,564 | — | ↗ |
| 2024-06-08 | Schneyer Mark C. | Officer | M-Exempt | A | Common Stock | 1,893 | 0.00 | — | 35,539 | — | ↗ |
| 2024-05-29 | SOLAND DANIEL B | Director | M-Exempt | A | Common Stock | 6,652 | 0.00 | — | 34,654 | — | ↗ |
| 2024-05-29 | Ndu Adora | Director | M-Exempt | D | Restricted Stock Units | 6,652 | 0.00 | — | 0 | — | ↗ |
| 2024-05-29 | HARRIGAN EDMUND | Director | A-Award | A | Restricted Stock Units | 9,387 | 0.00 | — | 9,387 | — | ↗ |
| 2024-05-29 | GAROFALO ELIZABETH A. | Director | A-Award | A | Restricted Stock Units | 9,387 | 0.00 | — | 9,387 | — | ↗ |
| 2024-05-29 | Daly James M | Director | M-Exempt | D | Restricted Stock Units | 6,652 | 0.00 | — | 0 | — | ↗ |
| 2024-05-29 | Brege Laura | Director | M-Exempt | A | Common Stock | 6,652 | 0.00 | — | 20,154 | — | ↗ |
| 2024-05-29 | BAKER BROS. ADVISORS LP | Director / 10% Owner | A-Award | A | Common Stock | 18,774 | 0.00 | — | 39,349,751 | — | ↗ |
| 2024-05-02 | Teehan Brendan | Officer | S-Sale | D | Common Stock | 3,477 | 16.94 | 58.9K | 42,133 | — | ↗ |
| 2024-05-02 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 3,503 | 16.94 | 59.3K | 32,053 | — | ↗ |
| 2024-05-02 | Kihara James | Officer | S-Sale | D | Common Stock | 1,326 | 16.94 | 22.5K | 14,370 | — | ↗ |
| 2024-05-02 | DAVIS STEPHEN | Director / Officer | S-Sale | D | Common Stock | 11,427 | 16.94 | 193.6K | 155,231 | — | ↗ |
| 2024-05-01 | Teehan Brendan | Officer | M-Exempt | D | Restricted Stock Units | 6,814 | 0.00 | — | 20,445 | — | ↗ |
| 2024-05-01 | Schneyer Mark C. | Officer | M-Exempt | D | Restricted Stock Units | 6,814 | 0.00 | — | 20,445 | — | ↗ |
| 2024-05-01 | Kihara James | Officer | M-Exempt | A | Common Stock | 2,596 | 0.00 | — | 15,696 | — | ↗ |
| 2024-05-01 | DAVIS STEPHEN | Director / Officer | M-Exempt | A | Common Stock | 22,391 | 0.00 | — | 166,658 | — | ↗ |
| 2024-04-08 | Teehan Brendan | Officer | S-Sale | D | Common Stock | 2,568 | 17.87 | 45.9K | 38,796 | — | ↗ |
| 2024-04-08 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 2,716 | 17.87 | 48.5K | 28,742 | — | ↗ |
| 2024-04-08 | Kihara James | Officer | S-Sale | D | Common Stock | 762 | 17.87 | 13.6K | 13,100 | — | ↗ |
| 2024-04-08 | DAVIS STEPHEN | Director / Officer | S-Sale | D | Common Stock | 17,716 | 17.87 | 316.6K | 144,267 | — | ↗ |
| 2024-04-07 | Kihara James | Officer | M-Exempt | D | Restricted Stock Units | 1,489 | 0.00 | — | 0 | — | ↗ |
| 2024-04-05 | Teehan Brendan | Officer | M-Exempt | D | Restricted Stock Units | 5,024 | 0.00 | — | 10,048 | — | ↗ |
| 2024-04-05 | Schneyer Mark C. | Officer | M-Exempt | A | Common Stock | 5,275 | 0.00 | — | 31,458 | — | ↗ |
| 2024-04-05 | Kihara James | Officer | M-Exempt | D | Restricted Stock Units | 2,010 | 0.00 | — | 4,020 | — | ↗ |
| 2024-04-05 | DAVIS STEPHEN | Director / Officer | M-Exempt | A | Common Stock | 17,333 | 0.00 | — | 136,175 | — | ↗ |
| 2024-04-04 | Thompson Elizabeth H.Z. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-27 | Teehan Brendan | Officer | S-Sale | D | Common Stock | 5,140 | 17.90 | 92.0K | 36,340 | — | ↗ |
| 2024-03-27 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 5,434 | 17.90 | 97.3K | 26,183 | — | ↗ |
| 2024-03-27 | DAVIS STEPHEN | Director / Officer | S-Sale | D | Common Stock | 17,714 | 17.90 | 317.1K | 118,842 | — | ↗ |
| 2024-03-25 | Teehan Brendan | Officer | A-Award | A | Restricted Stock Units | 27,460 | 0.00 | — | 27,460 | — | ↗ |
| 2024-03-25 | Schneyer Mark C. | Officer | A-Award | A | Stock Options (Right to Buy) | 80,564 | 17.84 | 1.44M | 80,564 | — | ↗ |
| 2024-03-25 | Kihara James | Officer | A-Award | A | Restricted Stock Units | 8,568 | 0.00 | — | 8,568 | — | ↗ |
| 2024-03-25 | DAVIS STEPHEN | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 286,451 | 17.84 | 5.11M | 286,451 | — | ↗ |
| 2024-02-26 | Teehan Brendan | Officer | S-Sale | D | Common Stock | 624 | 24.67 | 15.4K | 31,432 | — | ↗ |
| 2024-02-26 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 772 | 24.67 | 19.0K | 21,067 | — | ↗ |
| 2024-02-26 | Kihara James | Officer | S-Sale | D | Common Stock | 474 | 24.67 | 11.7K | 11,391 | — | ↗ |
| 2024-02-26 | DAVIS STEPHEN | Director / Officer | S-Sale | D | Common Stock | 5,577 | 24.67 | 137.6K | 101,890 | — | ↗ |
| 2024-02-23 | Teehan Brendan | Officer | M-Exempt | D | Restricted Stock Units | 1,107 | 0.00 | — | 1,107 | — | ↗ |
| 2024-02-23 | Schneyer Mark C. | Officer | M-Exempt | D | Restricted Stock Units | 1,353 | 0.00 | — | 1,353 | — | ↗ |
| 2024-02-23 | Kihara James | Officer | M-Exempt | D | Restricted Stock Units | 840 | 0.00 | — | 840 | — | ↗ |
| 2024-02-23 | DAVIS STEPHEN | Director / Officer | M-Exempt | D | Restricted Stock Units | 10,946 | 0.00 | — | 10,946 | — | ↗ |
| 2024-02-06 | Rhodes Jennifer J | Officer | A-Award | A | Stock Option (Right to Buy) | 126,589 | 25.74 | 3.26M | 126,589 | — | ↗ |
| 2024-01-08 | Teehan Brendan | Officer | S-Sale | D | Common Stock | 731 | 29.96 | 21.9K | 30,949 | — | ↗ |
| 2024-01-08 | KIM AUSTIN D. | Officer | S-Sale | D | Common Stock | 590 | 29.96 | 17.7K | 46,901 | — | ↗ |
| 2024-01-08 | DAVIS STEPHEN | Director / Officer | S-Sale | D | Common Stock | 3,732 | 29.96 | 111.8K | 96,521 | — | ↗ |
| 2024-01-06 | Teehan Brendan | Officer | M-Exempt | D | Restricted Stock Units | 1,287 | 0.00 | — | 0 | — | ↗ |
| 2024-01-06 | KIM AUSTIN D. | Officer | M-Exempt | A | Common Stock | 1,634 | 0.00 | — | 47,491 | — | ↗ |
| 2024-01-06 | DAVIS STEPHEN | Director / Officer | M-Exempt | D | Restricted Stock Units | 9,528 | 0.00 | — | 0 | — | ↗ |
| 2023-12-15 | Kihara James | Officer | S-Sale | D | Common Stock | 2,000 | 28.30 | 56.6K | 11,025 | — | ↗ |
| 2023-11-24 | GAROFALO ELIZABETH A. | Director | G-Gift | D | Common Stock | 2,918 | 0.00 | — | 15,862 | — | ↗ |
| 2023-11-20 | Teehan Brendan | Officer | S-Sale | D | Common Stock | 4,960 | 22.64 | 112.3K | 30,393 | — | ↗ |
| 2023-11-20 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 5,108 | 22.64 | 115.6K | 20,486 | — | ↗ |
| 2023-11-20 | Kihara James | Officer | S-Sale | D | Common Stock | 1,985 | 22.64 | 44.9K | 13,025 | — | ↗ |
| 2023-11-17 | Teehan Brendan | Officer | M-Exempt | D | Restricted Stock Units | 4,956 | 0.00 | — | 19,826 | — | ↗ |
| 2023-11-17 | Schneyer Mark C. | Officer | M-Exempt | D | Restricted Stock Units | 4,956 | 0.00 | — | 19,826 | — | ↗ |
| 2023-11-17 | Kihara James | Officer | M-Exempt | D | Restricted Stock Units | 1,982 | 0.00 | — | 7,931 | — | ↗ |
| 2023-10-12 | Ndu Adora | Director | M-Exempt | D | Restricted Stock Units | 4,381 | 0.00 | — | 4,381 | — | ↗ |
| 2023-10-06 | KIM AUSTIN D. | Officer | S-Sale | D | Common Stock | 16,369 | 21.96 | 359.5K | 45,857 | — | ↗ |
| 2023-10-06 | DAVIS STEPHEN | Director / Officer | M-Exempt | D | Restricted Stock Units | 103,999 | 0.00 | — | 173,332 | — | ↗ |
| 2023-10-05 | KIM AUSTIN D. | Officer | M-Exempt | D | Restricted Stock Units | 36,174 | 0.00 | — | 60,289 | — | ↗ |
| 2023-10-05 | DAVIS STEPHEN | Director / Officer | M-Exempt | A | Common Stock | 103,999 | 0.00 | — | 140,694 | — | ↗ |
| 2023-09-15 | Kihara James | Officer | S-Sale | D | Common Stock | 2,000 | 25.88 | 51.8K | 10,778 | — | ↗ |
| 2023-08-21 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 10,000 | 29.00 | 290.0K | 15,682 | — | ↗ |
| 2023-07-14 | DAVIS STEPHEN | Director / Officer | S-Sale | D | Common Stock | 100,000 | 30.04 | 3.00M | 36,695 | — | ↗ |
| 2023-07-12 | DAVIS STEPHEN | Director / Officer | S-Sale | D | Common Stock | 55,104 | 25.05 | 1.38M | 36,695 | — | ↗ |
| 2023-07-11 | DAVIS STEPHEN | Director / Officer | S-Sale | D | Common Stock | 16,498 | 25.00 | 412.5K | 91,799 | — | ↗ |
| 2023-06-15 | Kihara James | Officer | S-Sale | D | Common Stock | 2,000 | 24.15 | 48.3K | 9,144 | — | ↗ |
| 2023-06-12 | Brege Laura | Director | S-Sale | D | Common Stock | 4,500 | 24.87 | 111.9K | 13,502 | — | ↗ |
| 2023-06-08 | Schneyer Mark C. | Officer | M-Exempt | A | Common Stock | 1,893 | 0.00 | — | 23,798 | — | ↗ |
| 2023-06-01 | SOLAND DANIEL B | Director | M-Exempt | A | Common Stock | 8,552 | 0.00 | — | 28,002 | — | ↗ |
| 2023-06-01 | Ndu Adora | Director | A-Award | A | Restricted Stock Units | 6,652 | 0.00 | — | 6,652 | — | ↗ |
| 2023-06-01 | HARRIGAN EDMUND | Director | M-Exempt | D | Restricted Stock Units | 8,552 | 0.00 | — | 0 | — | ↗ |
| 2023-06-01 | GAROFALO ELIZABETH A. | Director | M-Exempt | A | Common Stock | 8,552 | 0.00 | — | 18,780 | — | ↗ |
| 2023-06-01 | Daly James M | Director | M-Exempt | A | Common Stock | 8,552 | 0.00 | — | 18,002 | — | ↗ |
| 2023-06-01 | Brege Laura | Director | M-Exempt | D | Restricted Stock Units | 8,552 | 0.00 | — | 0 | — | ↗ |
| 2023-06-01 | BAKER BROS. ADVISORS LP | Director / 10% Owner | A-Award | A | Common Stock | 13,304 | 0.00 | — | 39,330,977 | — | ↗ |
| 2023-05-24 | BAKER BROS. ADVISORS LP | Director / 10% Owner | P-Purchase | A | Common Stock | 218,171 | 25.27 | 5.51M | 39,029,686 | — | ↗ |
| 2023-05-23 | BAKER BROS. ADVISORS LP | Director / 10% Owner | P-Purchase | A | Common Stock | 116,672 | 25.33 | 2.96M | 38,736,933 | — | ↗ |
| 2023-05-22 | BAKER BROS. ADVISORS LP | Director / 10% Owner | P-Purchase | A | Common Stock | 40,632 | 24.80 | 1.01M | 38,607,761 | — | ↗ |
| 2023-05-17 | Teehan Brendan | Officer | S-Sale | D | Common Stock | 14,869 | 22.50 | 334.6K | 24,356 | — | ↗ |
| 2023-05-17 | Schneyer Mark C. | Officer | M-Exempt | D | Restricted Stock Units | 14,869 | 0.00 | — | 24,782 | — | ↗ |
| 2023-05-17 | Kihara James | Officer | S-Sale | D | Common Stock | 5,947 | 22.50 | 133.8K | 11,144 | — | ↗ |
| 2023-05-01 | Teehan Brendan | Officer | A-Award | A | Restricted Stock Units | 27,259 | 0.00 | — | 27,259 | — | ↗ |
| 2023-05-01 | Schneyer Mark C. | Officer | A-Award | A | Restricted Stock Units | 27,259 | 0.00 | — | 27,259 | — | ↗ |
| 2023-05-01 | Kihara James | Officer | A-Award | A | Stock Options (Right to Buy) | 17,131 | 21.75 | 372.6K | 17,131 | — | ↗ |
| 2023-05-01 | KIM AUSTIN D. | Officer | A-Award | A | Restricted Stock Units | 18,172 | 0.00 | — | 18,172 | — | ↗ |
| 2023-05-01 | DAVIS STEPHEN | Director / Officer | A-Award | A | Restricted Stock Units | 89,564 | 0.00 | — | 89,564 | — | ↗ |
| 2023-04-29 | Teehan Brendan | Officer | M-Exempt | A | Common Stock | 1,567 | 0.00 | — | 10,035 | — | ↗ |
| 2023-04-29 | KIM AUSTIN D. | Officer | M-Exempt | D | Restricted Stock Units | 3,005 | 0.00 | — | 0 | — | ↗ |
| 2023-04-29 | DAVIS STEPHEN | Director / Officer | M-Exempt | A | Common Stock | 15,625 | 0.00 | — | 116,103 | — | ↗ |
| 2023-04-10 | Kihara James | Officer | S-Sale | D | Common Stock | 523 | 18.14 | 9.5K | 5,197 | — | ↗ |
| 2023-04-07 | Kihara James | Officer | M-Exempt | A | Common Stock | 1,489 | 0.00 | — | 5,720 | — | ↗ |
| 2023-04-06 | Teehan Brendan | Officer | S-Sale | D | Common Stock | 1,751 | 18.16 | 31.8K | 8,468 | — | ↗ |
| 2023-04-06 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 1,916 | 18.16 | 34.8K | 7,477 | — | ↗ |
| 2023-04-06 | Kihara James | Officer | S-Sale | D | Common Stock | 701 | 18.16 | 12.7K | 4,231 | — | ↗ |
| 2023-04-06 | KIM AUSTIN D. | Officer | S-Sale | D | Common Stock | 1,456 | 18.16 | 26.4K | 23,425 | — | ↗ |
| 2023-04-06 | DAVIS STEPHEN | Director / Officer | S-Sale | D | Common Stock | 8,582 | 18.16 | 155.8K | 100,478 | — | ↗ |
| 2023-04-05 | Teehan Brendan | Officer | M-Exempt | A | Common Stock | 5,024 | 0.00 | — | 10,219 | — | ↗ |
| 2023-04-05 | Schneyer Mark C. | Officer | M-Exempt | D | Restricted Stock Units | 5,275 | 0.00 | — | 15,826 | — | ↗ |
| 2023-04-05 | Kihara James | Officer | M-Exempt | A | Common Stock | 2,009 | 0.00 | — | 4,932 | — | ↗ |
| 2023-04-05 | KIM AUSTIN D. | Officer | M-Exempt | D | Restricted Stock Units | 4,773 | 0.00 | — | 14,319 | — | ↗ |
| 2023-04-05 | DAVIS STEPHEN | Director / Officer | M-Exempt | D | Restricted Stock Units | 17,333 | 0.00 | — | 52,000 | — | ↗ |
| 2023-02-24 | Teehan Brendan | Officer | S-Sale | D | Common Stock | 461 | 18.78 | 8.7K | 5,195 | — | ↗ |
| 2023-02-24 | Schneyer Mark C. | Officer | S-Sale | D | Common Stock | 577 | 18.78 | 10.8K | 4,118 | — | ↗ |
| 2023-02-24 | Kihara James | Officer | S-Sale | D | Common Stock | 350 | 18.78 | 6.6K | 2,923 | — | ↗ |
| 2023-02-24 | KIM AUSTIN D. | Officer | S-Sale | D | Common Stock | 803 | 18.78 | 15.1K | 20,108 | — | ↗ |
| 2023-02-24 | DAVIS STEPHEN | Director / Officer | S-Sale | D | Common Stock | 3,851 | 18.78 | 72.3K | 91,727 | — | ↗ |
| 2023-02-23 | Teehan Brendan | Officer | M-Exempt | A | Common Stock | 1,107 | 0.00 | — | 5,656 | — | ↗ |
| 2023-02-23 | Schneyer Mark C. | Officer | M-Exempt | D | Restricted Stock Units | 1,353 | 0.00 | — | 2,706 | — | ↗ |
| 2023-02-23 | Kihara James | Officer | M-Exempt | A | Common Stock | 840 | 0.00 | — | 3,273 | — | ↗ |
| 2023-02-23 | KIM AUSTIN D. | Officer | M-Exempt | A | Common Stock | 2,214 | 0.00 | — | 20,911 | — | ↗ |
| 2023-02-23 | DAVIS STEPHEN | Director / Officer | M-Exempt | D | Restricted Stock Units | 10,945 | 0.00 | — | 21,892 | — | ↗ |
| 2023-02-10 | Williamson Douglas J | Officer | A-Award | A | Restricted Stock Units | 50,655 | 0.00 | — | 50,655 | — | ↗ |
Executive team
Top executives
EBIT / Employee
212.7K
Shares Outstanding
171.22M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Catherine E. Owen Adams | Chief Executive Officer & Director | 2M | female |
| Elizabeth Thompson | Executive Vice President and Head of Research & Development | 1M | — |
| Mark C. Schneyer | Executive Vice President & Chief Financial Officer | 877.9K | male |
| Jennifer J. Rhodes | Executive Vice President, Chief Legal Officer & Secretary | 857.9K | female |
| Thomas Andrew Garner | Executive Vice President & Chief Commercial Officer | 857.0K | male |
| James K. Kihara | Senior Vice President of Finance | — | male |
| Konstantina Katcheves | Senior Vice President, Chief Business & Strategy Officer | — | female |
| Allyson McMillan Youngblood | Senior Vice President of Rare Disease Franchise | — | female |
| Rob Ackles | Senior Vice President & Chief People Officer | — | male |
| Scott Cenci | Senior Vice President, Chief Information & Data Officer | — | male |
| Albert S. Kildani | Senior Vice President of Investor Relations & Corporate Communications | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ACAD
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
